Symphysis Medical

Independence | Comfort | Quality of Life

Developing an innovative drainage technology to treat malignant pleural effusions (MPE)

Better Outcomes



Incorporates an active component that will significantly shorten the treatment duration of MPE compared to current catheter devices.


Patient Centric


A user-friendly design to promote patient independence, comfort and quality of life.

Cost Effective


Reduces the costs associated with long-term home drainage and acute readmissions to hospital.


SymPhysis Medical

Located in Galway, Ireland


linked to experts internationally


University of Galway IdeasLab showcase …

Posted in News by Nate Reynolds

7th June, 2024

Natalie Walsh, from University of Galway IdeasLab, presented the Empathy Studio in partnership with Boston Scientific and SymPhysis Medical at the University Industry Innovation Network (UIIN) conference in Madrid last...

Read more

SymPhysis Medical showcase in San Diego

Posted in News by Nate Reynolds

6th June, 2024

SymPhysis Medical CEO, Tim Jones, and VP of Marketing & Sales, Joe Villanova, had the privilege of joining fellow respiratory and pulmonology innovators at the recent American Thoracic Society Respiratory...

Read more

Symphysis Medical close out the year wit…

Posted in News by Nate Reynolds

19th December, 2023

What a year it has been! Finishing on what has been an eventful year, Symphysis Medical are extremely grateful for days like Thursday, 7th December, 2023 at the Irish Medtech...

Read more

SymPhysis Medical receive multiple nomin…

Posted in News by Nate Reynolds

20th November, 2023

November is proving to be a fruitful month this year as SymPhysis Medical have been nominated for not one but three awards. Firstly, the Excellence in Innovation Award is a part...

Read more

MPE By Numbers


Affects ~90% of patients with mesothelioma.

Lung Cancer

Affects ~ 35% of patients with lung cancer.

Breast Cancer

Affects ~ 16% of patients with breast cancer.


Affects ~ 11% of patients with lymphoma.